Tags: Drug.

Alvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist that was under investigation for the treatment of Alzheimer’s disease but produced poor results in clinical trials and was subsequently discontinued.

Alvameline.png
ATC prefix
None
CAS number
120241-31-8
FDA UNII code
4XFD7B36M6
IUPAC name
3-(2-ethyltetrazol-5-yl)-1-methyl-56-dihydro-2H-pyridine
PubChem
178030

Loading...

This page contains content from the copyrighted Wikipedia article "Alvameline"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.